- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Narayana Hrudayalaya's Q1 FY26 saw Cayman EBITDA decline due to its new, currently loss-making Integrated Care business (INR 9.3 Cr negative impact). India's average revenue per patient (ARPP) grew from price increases, a favorable payor mix, and high-end procedures like cardiac robotic surgeries. Management expects Cayman's Integrated Care to break even by year-end/early next year, driving absolute earnings growth. Oncology is targeted for significant revenue growth in India over five years. New hospital projects will initially impact margins, which the company aims to minimize. The insurance business is growing with 6,000 policyholders, focusing on direct distribution for affordability. Digitalization continues to boost operational efficiency.